Primate reactivity reported in (PMID: 22875974), Rat reactivity reported in (PMID: 22740409). Mouse reactivity reported in scientific literature (DOI 10.21007/etd.cghs.2016.0419).
Packaging, Storage & Formulations
Store at 4C. Do not freeze.
TBS and 0.1% BSA
0.09% Sodium Azide
Immunogen affinity purified
Alternate Names for SEC16A Antibody
p250protein SEC16 homolog A
SEC16 homolog A (S. cerevisiae)
SEC16 homolog A
SEC16Lprotein transport protein Sec16A
KIAA0310 was first identified as a hypothetical protein predicted from the in silico analysis of long cDNAs isolated in the Kazusa cDNA sequencing project. KIAA0310 appears to be the human Sec16 homolog. In budding yeast, Sec16 is an endoplasmic reticulum membrane protein that functions in vesicle transport through an interaction with COPII. Alternate names for KIAA0310 include SEC16 homolog A, SEC16A, SEC16L, p250, and RP11-413M.10.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our SEC16A Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.